Theragenics Corporation (TGX)
Add to Watchlists Create an AlertTGX Key Stats
| Income Statement | |
| Revenue TTM | 82.56M |
| Revenue Quarterly YoY Growth | -3.90% |
| EPS Diluted TTM | 0.0588 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | 2.139M |
| Profitability | |
| Gross Profit Margin Quarterly | 33.89% |
| Profit Margin Quarterly | -1.69% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 62.57M |
| Enterprise Value | 49.66M |
| PE Ratio TTM | 34.25 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 0.8133 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.286 |
| Free Cash Flow | 3.384M |
| Return on Equity | 2.61% |
TGX News
- SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of... May 24
- Lifshitz Law Firm Announces Investigation of Chemed Corporation, Overhill Farms,... May 22
- SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of... May 22
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible B... May 21
- THERAGENICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security... May 21
- Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Theragenics Co... May 20
- Theragenics Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investiga... May 20
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible B... May 20
- THERAGENICS CORP Financials May 17
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible B... May 17
TGX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Theragenics Corporation is up 19.23% over the last year vs S&P 500 Total Return up 27.77%, IsoRay down 29.12%, and C.R. Bard up 5.98%.
TGX Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these TGX related companies
Pro Ratings for TGX
Pro Report PDF for TGX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download TGX Pro Report PDF
Pro Strategies Featuring TGX
Did Theragenics Corporation make it into our Pro Portfolio Strategies?
TGX Profile
Sector: Healthcare
Industry: Medical Devices
Other TGX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TGX | 2.015 | +0.01 | +0.25% | 62.57M |
